The Contribution of Key Enzyme-Substrate Interactions to the Cytochrome P450 Catalyzed Dehydrogenation of Tamoxifen Metabolites and the Role of P450 Conformational Dynamics during Tamoxifen Metabolism

被引：0
|
作者：
Shahrokh, Kiumars [1 ]
Yost, Garold S. [1 ]
Cheatham, Thomas E., III [2 ,3 ,4 ]
机构：
[1] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Med Chem, Salt Lake City, UT 84117 USA
[3] Univ Utah, Dept Pharmaceut, Salt Lake City, UT 84117 USA
[4] Univ Utah, Dept Pharmaceut Chem, Salt Lake City, UT 84117 USA
来源：
CHEMICAL RESEARCH IN TOXICOLOGY | 2008年 / 21卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
22
引用
收藏
页码：2437 / 2437
页数：1
相关论文
共 50 条
  • [1] COMP 331-The potential energy surface for the dehydrogenation of 4-hydroxy-tamoxifen and contribution of P450 conformational dynamics to enzyme-substrate interactions during tamoxifen metabolism
    Shahrokh, Kiumars
    Yost, Garold S.
    Cheatham, Thomas E., III
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [2] Effects of cytochrome P450 polymorphisms on tamoxifen metabolism.
    Sawyer, MB
    Damaraju, S
    Pituskin, E
    Carter, SJ
    Dufour, J
    Carandang, D
    Hanson, J
    Mackey, JR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 148S - 148S
  • [3] Classification Models for Predicting Cytochrome P450 Enzyme-Substrate Selectivity
    Zhang, Tao
    Dai, Hao
    Liu, Limin Angela
    Lewis, David F. V.
    Wei, Dongqing
    MOLECULAR INFORMATICS, 2012, 31 (01) : 53 - 62
  • [4] Tamoxifen metabolism by microsomal cytochrome P450 and flavin-containing monooxygenase
    Kupfer, D
    Dehal, SS
    CYTOCHROME P450, PT B, 1996, 272 : 152 - 163
  • [5] Cytochrome P450 structures and their substrate interactions
    Lewis, DFV
    Ito, Y
    Goldfarb, PS
    DRUG DEVELOPMENT RESEARCH, 2005, 66 (01) : 19 - 24
  • [6] Polymorphisms of cytochrome p450 and adverse events of tamoxifen therapy
    Ignatova, A.
    Zacharenkova, J.
    Dudina, I.
    Savelyeva, M.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S20 - S21
  • [7] Bioactivation of tamoxifen by recombinant human cytochrome P450 enzymes
    Notley, LM
    de Wolf, CJF
    Wunsch, RM
    Gillam, EMJ
    TOXICOLOGY, 2001, 164 (1-3) : 139 - 139
  • [8] Bioactivation of tamoxifen by recombinant human cytochrome P450 enzymes
    Notley, LM
    de Wolf, CJF
    Wunsch, RM
    Lancaster, RG
    Gillam, EMJ
    CHEMICAL RESEARCH IN TOXICOLOGY, 2002, 15 (05) : 614 - 622
  • [9] Enzyme-substrate binding interaction energies and their application to the cytochrome P450 system
    Lewis, David F. V.
    Ito, Yuko
    Goldfarb, Peter S.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2008, 4 (02) : 111 - 122
  • [10] Fluoxetine metabolism and pharmacological interactions: The role of cytochrome P450
    Mandrioli, R
    Forti, GC
    Raggi, MA
    CURRENT DRUG METABOLISM, 2006, 7 (02) : 127 - 133
12345